Summary & Overview
HCPCS C9807: Percutaneous Peripheral Nerve Stimulator for Post-Surgical Pain
HCPCS Level II code C9807 represents a percutaneous peripheral nerve stimulator system designated as a qualifying non-opioid medical device for post-surgical pain relief under section 4135 of the CAA, 2023. The code includes the stimulator, electrode and all disposable system components. Its national relevance stems from expanding non-opioid pain management options and evolving coverage requirements tied to federal non-opioid initiative language.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical application of the device, typical sites of service, and the payer landscape relevant to coverage considerations. The publication summarizes expected benchmarks for utilization and reimbursement where available, highlights policy updates driven by the federal non-opioid device designation, and outlines clinical context for use in post-operative analgesia.
The content aims to inform billing managers, revenue cycle leaders, and clinical program directors about the code purpose, payer coverage scope, and areas where payers may apply medical necessity or device qualification criteria. Data not provided in the input — including specific payer policy language, associated ICD-10 diagnoses, and related procedure or supply codes — is noted as not available for this summary.
Billing Code Overview
HCPCS Level II code C9807 describes a percutaneous peripheral nerve stimulator system intended as a non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the CAA, 2023. The code covers the complete disposable system components, including the electrode and all consumable parts associated with the device (example: sprint peripheral nerve stimulation system).
Service type: Durable medical device/non-opioid neuromodulation therapy intended for short-term, post-surgical pain management delivered via percutaneous peripheral nerve stimulation.
Typical site of service: Outpatient procedural settings or ambulatory surgical centers, and other clinical environments where percutaneous peripheral nerve stimulation may be applied for post-surgical analgesia.
Clinical & Coding Specifications
Clinical Context
A 54-year-old patient presents with persistent, focal post-surgical neuropathic pain of the distal lower extremity following ankle fusion performed 10 weeks earlier. Conservative measures including oral analgesics, physical therapy, and a short opioid taper provided inadequate relief. The treating pain medicine specialist evaluates the patient in the outpatient pain clinic, documents neuropathic pain localized to a peripheral nerve distribution, and determines the patient meets clinical criteria for a qualifying Medicare non-opioid medical device under Section 4135 of the CAA (2023) for post-surgical pain relief. In the clinic procedure suite, the provider performs a percutaneous peripheral nerve stimulator implant (device includes electrode and disposable components) using fluoroscopic and ultrasound guidance to place a temporary percutaneous electrode adjacent to the targeted peripheral nerve. The procedure includes sterile prep, local anesthesia, test stimulation to confirm paresthesia coverage, device connection, and post-procedure patient education about device troubleshooting and follow-up. The typical site of service is an outpatient ambulatory surgery center or hospital outpatient department; in some cases an accredited office-based procedure suite may be used when local regulations and payer policies permit. Post-procedure follow-up visits are scheduled to assess pain relief and decide on continued use, device removal, or conversion to a longer-term system as clinically indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |